Article
In-Depth Look at a Community- Based Population of Multiple Myeloma (MM) Patients Undergoing an in-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib in the United States (US) MM-6 Study
- Author:
- Suman Kambhampati
- Ramalingam Ratnasabapathy
- Eddie Thara
- Leonid Shunyakov
- Joshua Richter
- Ruemu E. Birhiray
- Saulius K. Girnius
- January Fields-Meehan
- Ralph V. Boccia
- Jack Aiello
- Kimberly Bogard
- Presley Whidden
- Dasha Cherepanov
- Vickie Lu
- Stephen J. Noga
- Robert M. Rifkin
Publish date: September 2, 2020